{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:23:53Z","timestamp":1794489833148,"version":"4.9.1"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Benign prostatic hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS) can significantly impair a man\u2019s quality of life. While traditional surgical treatments are effective, they often pose risks to sexual function, particularly in the form of ejaculatory and\/or erectile dysfunction. Minimally invasive surgical treatments (MISTs) have emerged as alternative procedures that aim to alleviate LUTS while preserving sexual function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Investigate the impact of MISTs for BPH on sexual function including erectile and ejaculatory function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In May 2025, a systematic review and meta-analysis of sexual function outcomes in MISTs was performed using the Ovid, Embase, and Medline\/PubMed databases. Articles were included if they were in English, assessed a MIST, and incorporated sexual function outcomes. Articles were excluded if they included pooled analyses, were abstracts without full text, and\/or were ongoing incomplete clinical trials. We included studies on water vapor thermal therapy (Rezum), prostatic urethral lift (Urolift), prostatic artery embolization (PAE), temporary implantable nitinol device (iTIND), Optilume BPH catheter system, and transperineal laser ablation (TPLA). Outcomes included erectile function using International Index of Erectile Function (IIEF) scores and ejaculatory function using the Male Sexual Health Questionnaire (MSHQ).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The initial search yielded 2646 studies. After screening and full text review, 77 studies met inclusion criteria encompassing a total of 11,477 patients. Based on the pooled analyses, IIEF scores significantly improved after Rezum and Urolift. Urolift significantly improved MSHQ-function and bother scores, while Rezum only improved MSHQ-bother scores. PAE, iTind, Optilume, and TPLA did not significantly impact erectile or ejaculatory function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MISTs are a promising option for management of BPH in patients interested in maintaining sexual function, preserving or even improving erectile and ejaculatory function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41391-026-01091-x","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:18:47Z","timestamp":1772558327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of minimally invasive surgical therapy for Benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0459-534X","authenticated-orcid":false,"given":"Ellen M.","family":"Cahill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo Mass","family":"Lindenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5707-0448","authenticated-orcid":false,"given":"Alexander","family":"Estright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardita M.","family":"Ljubetic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Aslot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8391-4785","authenticated-orcid":false,"given":"Neil","family":"Nero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Bajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raevti","family":"Bole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/0970-1591.126900","volume":"30","author":"ND Patel","year":"2014","unstructured":"Patel ND, Parsons JK. Epidemiology and etiology of Benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014;30:170\u20136. https:\/\/doi.org\/10.4103\/0970-1591.126900.","journal-title":"Indian J Urol"},{"key":"1091_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/smrj.20","volume":"2","author":"EF Becher","year":"2014","unstructured":"Becher EF, McVary KT. Surgical procedures for BPH\/LUTS: impact on male sexual health. Sex Med Rev. 2014;2:47\u201355. https:\/\/doi.org\/10.1002\/smrj.20.","journal-title":"Sex Med Rev"},{"key":"1091_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/ju.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, et al. Management of lower urinary tract symptoms attributed to Benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211:11\u201319. https:\/\/doi.org\/10.1097\/ju.0000000000003698.","journal-title":"J Urol"},{"key":"1091_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00345-025-05727-w","volume":"43","author":"F Passarelli","year":"2025","unstructured":"Passarelli F, Castellani D, Secco S, Gacci M, Sibona M, Goumas IK, et al. Minimally invasive surgical techniques (MISTs) for Benign prostatic hyperplasia: results from a Delphi consensus project to shed light on controversial topics. World J Urol. 2025;43:363 https:\/\/doi.org\/10.1007\/s00345-025-05727-w.","journal-title":"World J Urol"},{"key":"1091_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41443-019-0158-3","volume":"31","author":"G Reale","year":"2019","unstructured":"Reale G, Cimino S, Bruno G, Palmieri F, Giardina R, Russo GI, et al. \u201cAquabeam\u00ae System\u201d for Benign prostatic hyperplasia and LUTS: birth of a new era. A systematic review of functional and sexual outcome and adverse events of the technique. Int J Impot Res. 2019;31:392\u20139. https:\/\/doi.org\/10.1038\/s41443-019-0158-3.","journal-title":"Int J Impot Res"},{"key":"1091_CR6","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71 https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"1091_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt C, Adams MB, Owens T, Keitz S, Fontelo P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med Inf Decis Mak. 2007;7:16. https:\/\/doi.org\/10.1186\/1472-6947-7-16.","journal-title":"BMC Med Inf Decis Mak"},{"key":"1091_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol. 2014;14:135. https:\/\/doi.org\/10.1186\/1471-2288-14-135.","journal-title":"BMC Med Res Methodol"},{"key":"1091_CR9","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj. 2016;355:i4919 https:\/\/doi.org\/10.1136\/bmj.i4919.","journal-title":"Bmj"},{"key":"1091_CR10","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj. 2019;366:l4898 https:\/\/doi.org\/10.1136\/bmj.l4898.","journal-title":"Bmj"},{"key":"1091_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00345-024-05433-z","volume":"43","author":"C Ag\u00fcero","year":"2025","unstructured":"Ag\u00fcero C, Depaquit TL, Uleri A, Berchiche W, Corral R, Peyrottes A, et al. Water vapor thermal therapy for treatment of lower urinary tract symptoms due to large Benign prostatic hyperplasia (\u2265\u200980 g). World J Urol. 2025;43:69 https:\/\/doi.org\/10.1007\/s00345-024-05433-z.","journal-title":"World J Urol"},{"key":"1091_CR12","doi-asserted-by":"publisher","unstructured":"Ahn ST, Lee DH, Cho SB, Lee HS, Han DE, Park TY, et al. Is prostate urethral lift effective in patients with multiple comorbidities? J Clin Med. 2022;11 https:\/\/doi.org\/10.3390\/jcm11071928","DOI":"10.3390\/jcm11071928"},{"key":"1091_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.urology.2022.01.039","volume":"165","author":"O Aladesuru","year":"2022","unstructured":"Aladesuru O, Amankwah K, Elterman D, Zorn KC, Bhojani N, Te A, et al. Pilot study of \u201cLess is More\u201d rezum for treatment of BPH. Urology. 2022;165:256\u201360. https:\/\/doi.org\/10.1016\/j.urology.2022.01.039.","journal-title":"Urology"},{"key":"1091_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.purol.2020.05.004","volume":"30","author":"C Alegorides","year":"2020","unstructured":"Alegorides C, Fourmarier M, Eghazarian C, Lebdai S, Chevrot A, Droupy S. Treatment of Benign prostate hyperplasia using the Rezum\u00ae water vapor therapy system: results at one year. Prog Urol. 2020;30:624\u201331. https:\/\/doi.org\/10.1016\/j.purol.2020.05.004.","journal-title":"Prog Urol"},{"key":"1091_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13454","volume":"74","author":"SF Al Rawashdah","year":"2020","unstructured":"Al Rawashdah SF, Pastore AL, Velotti G, Fuschi A, Capone L, Suraci PP, et al. Sexual and functional outcomes of prostate artery embolisation: a prospective long-term follow-up, large cohort study. Int J Clin Pr. 2020;74:e13454. https:\/\/doi.org\/10.1111\/ijcp.13454.","journal-title":"Int J Clin Pr"},{"key":"1091_CR16","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1080\/13645706.2020.1816554","volume":"31","author":"W Al-Singary","year":"2022","unstructured":"Al-Singary W, Patel R, Obi-Njoku O, Patel HRH. The UroLift(\u00ae) System for lower urinary tract obstruction: patient selection for optimum clinical outcome. Minim Invasive Ther Allied Technol. 2022;31:456\u201361. https:\/\/doi.org\/10.1080\/13645706.2020.1816554.","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"1091_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41391-020-00281-5","volume":"24","author":"D Amparore","year":"2021","unstructured":"Amparore D, Fiori C, Valerio M, Schulman C, Giannakis I, De Cillis S, et al. 3-Year results following treatment with the second generation of the temporary implantable nitinol device in men with LUTS secondary to Benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2021;24:349\u201357. https:\/\/doi.org\/10.1038\/s41391-020-00281-5.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1091_CR18","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/iju.15621","volume":"32","author":"G Anan","year":"2025","unstructured":"Anan G, Minami H, Fujishima Y, Kaga K. Efficacy and safety of prostatic urethral lift according to preoperative urinary retention and prostate volume: A Japanese real-world multicenter data. Int J Urol. 2025;32:190\u20137. https:\/\/doi.org\/10.1111\/iju.15621.","journal-title":"Int J Urol"},{"key":"1091_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00345-024-05127-6","volume":"42","author":"P Annese","year":"2024","unstructured":"Annese P, d\u2019Altilia N, Falagario UG, Tocci E, Mirone V, Simone G, et al. UroLift to preserve seminal parameters in young male with LUTS from BPH. World J Urol. 2024;42:486 https:\/\/doi.org\/10.1007\/s00345-024-05127-6.","journal-title":"World J Urol"},{"key":"1091_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/17562872211037109","volume":"13","author":"P Annese","year":"2021","unstructured":"Annese P, d\u2019Altilia N, Mancini V, Falagario UG, Del Giudice F, Ferro M, et al. Preserving ejaculatory function in young patients with lower urinary tract symptoms: medium- to long-term follow-up of prostatic urethral lift at a single center. Ther Adv Urol. 2021;13:17562872211037109. https:\/\/doi.org\/10.1177\/17562872211037109.","journal-title":"Ther Adv Urol"},{"key":"1091_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/end.2022.0390","volume":"37","author":"M Babar","year":"2023","unstructured":"Babar M, Loloi J, Azhar U, Tang K, Ines M, Singh S, et al. Rezum outcomes in relationship to number of injections: is less more? J Endourol. 2023;37:157\u201364. https:\/\/doi.org\/10.1089\/end.2022.0390.","journal-title":"J Endourol"},{"key":"1091_CR22","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s11255-021-02899-3","volume":"53","author":"M Baboudjian","year":"2021","unstructured":"Baboudjian M, Fourmarier M, Gondran-Tellier B, Pradere B, Userovici M, Alegorides C, et al. Head-to-head comparison of prostatic urethral lift and water vapor thermal therapy for the treatment of symptomatic Benign prostatic hyperplasia: a real-life study. Int Urol Nephrol. 2021;53:1757\u201363. https:\/\/doi.org\/10.1007\/s11255-021-02899-3.","journal-title":"Int Urol Nephrol"},{"key":"1091_CR23","doi-asserted-by":"publisher","first-page":"759","DOI":"10.23736\/s2724-6051.24.05883-x","volume":"76","author":"R Balsamo","year":"2024","unstructured":"Balsamo R, Tammaro S, Trivellato M, Crocetto F, Barone B, Fusco F, et al. Water vapor thermal therapy (Rez\u016bm System) in patients with large prostates: results from a prospective comparative study. Minerva Urol Nephrol. 2024;76:759\u201367. https:\/\/doi.org\/10.23736\/s2724-6051.24.05883-x.","journal-title":"Minerva Urol Nephrol"},{"key":"1091_CR24","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fruro.2022.960875","volume":"ume 2","author":"R Bertolo","year":"2022","unstructured":"Bertolo R, Cipriani C, Giuliani MS, Maiorino F, Vittori M, Carilli M, et al. Prostatic arterial embolization as a micro-invasive treatment option for Benign prostatic obstruction: a subtle balance between short-term follow-up patient-reported outcomes and de-obstructive effectiveness. Community Case Study Front Urol. 2022;ume 2:2022 https:\/\/doi.org\/10.3389\/fruro.2022.960875.","journal-title":"Community Case Study Front Urol"},{"key":"1091_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/bju.16008","volume":"132","author":"R Bertolo","year":"2023","unstructured":"Bertolo R, Iacovelli V, Cipriani C, Carilli M, Vittori M, Antonucci M, et al. Ejaculatory function following transperineal laser ablation vs TURP for Benign prostatic obstruction: a randomized trial. BJU Int. 2023;132:100\u20138. https:\/\/doi.org\/10.1111\/bju.16008.","journal-title":"BJU Int"},{"key":"1091_CR26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jsxm.2022.01.006","volume":"19","author":"S Bhatia","year":"2022","unstructured":"Bhatia S, Acharya V, Jalaeian H, Kumar J, Bryant E, Richardson A, et al. Effect of prostate artery embolization on erectile function - a single center experience of 167 patients. J Sex Med. 2022;19:594\u2013602. https:\/\/doi.org\/10.1016\/j.jsxm.2022.01.006.","journal-title":"J Sex Med"},{"key":"1091_CR27","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/s41391-022-00587-6","volume":"26","author":"D Campobasso","year":"2023","unstructured":"Campobasso D, Siena G, Chiodini P, Conti E, Franzoso F, Maruzzi D, et al. Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study. Prostate Cancer Prostatic Dis. 2023;26:410\u20134. https:\/\/doi.org\/10.1038\/s41391-022-00587-6.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1091_CR28","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1007\/s11255-023-03717-8","volume":"55","author":"HL Canat","year":"2023","unstructured":"Canat HL, Gurbuz C, Bozkurt M. Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to Benign prostatic hyperplasia (BPH): prospective and comparative study. Int Urol Nephrol. 2023;55:2747\u201352. https:\/\/doi.org\/10.1007\/s11255-023-03717-8.","journal-title":"Int Urol Nephrol"},{"key":"1091_CR29","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/bju.12540","volume":"113","author":"AL Cantwell","year":"2014","unstructured":"Cantwell AL, Bogache WK, Richardson SF, Tutrone RF, Barkin J, Fagelson JE, et al. Multicentre prospective crossover study of the \u2018prostatic urethral lift\u2019 for the treatment of lower urinary tract symptoms secondary to Benign prostatic hyperplasia. BJU Int. 2014;113:615\u201322. https:\/\/doi.org\/10.1111\/bju.12540.","journal-title":"BJU Int"},{"key":"1091_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","volume":"39","author":"FC Carnevale","year":"2016","unstructured":"Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to Benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Inter Radio. 2016;39:44\u201352. https:\/\/doi.org\/10.1007\/s00270-015-1202-4.","journal-title":"Cardiovasc Inter Radio"},{"key":"1091_CR31","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1089\/end.2022.0385","volume":"36","author":"CP Chin","year":"2022","unstructured":"Chin CP, Garden EB, Ravivarapu KT, Shukla D, Omidele O, Levy M, et al. Medium-term real-world outcomes of minimally invasive surgical therapies for Benign prostatic hyperplasia: water vapor thermal therapy (rezum) vs prostatic urethral lift (UroLift) in a high-volume urban academic center. J Endourol. 2022;36:1559\u201366. https:\/\/doi.org\/10.1089\/end.2022.0385.","journal-title":"J Endourol"},{"key":"1091_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1089\/end.2022.0637","volume":"37","author":"L Cindolo","year":"2023","unstructured":"Cindolo L, Campobasso D, Conti E, Uricchio F, Franzoso F, Maruzzi D, et al. Do patients treated with water vapor therapy and meeting randomized clinical trial criteria have better urinary and sexual outcomes than an unselected cohort?. J Endourol. 2023;37:323\u20139. https:\/\/doi.org\/10.1089\/end.2022.0637.","journal-title":"J Endourol"},{"key":"1091_CR33","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1093\/jsxmed\/qdae206","volume":"22","author":"O Copelan","year":"2025","unstructured":"Copelan O, Moss J, Freedman S, Coutinho K, Elterman D, Marotte J, et al. Preservation of sexual function with Optilume-a novel treatment for lower urinary tract symptoms secondary to Benign prostatic hyperplasia. J Sex Med. 2025;22:446\u201353. https:\/\/doi.org\/10.1093\/jsxmed\/qdae206.","journal-title":"J Sex Med"},{"key":"1091_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70565","volume":"8","author":"S Delazar","year":"2025","unstructured":"Delazar S, Azadnajafabad S, Firouznia K, Nowroozi MR, Amini E, Fotouhi M, et al. Outcomes of prostatic artery embolization for treating Benign prostatic hyperplasia symptoms: a prospective single-center study. Health Sci Rep. 2025;8:e70565. https:\/\/doi.org\/10.1002\/hsr2.70565.","journal-title":"Health Sci Rep"},{"key":"1091_CR35","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1007\/s00345-020-03418-2","volume":"39","author":"C De Nunzio","year":"2021","unstructured":"De Nunzio C, Cantiello F, Fiori C, Crocerossa F, Tognoni P, Amparore D, et al. Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study. World J Urol. 2021;39:2037\u201342. https:\/\/doi.org\/10.1007\/s00345-020-03418-2.","journal-title":"World J Urol"},{"key":"1091_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.eururo.2020.08.018","volume":"80","author":"G de Rienzo","year":"2021","unstructured":"de Rienzo G, Lorusso A, Minafra P, Zingarelli M, Papapicco G, Lucarelli G, et al. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of Benign prostatic obstruction. Eur Urol. 2021;80:95\u2013103. https:\/\/doi.org\/10.1016\/j.eururo.2020.08.018.","journal-title":"Eur Urol"},{"key":"1091_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2147\/rru.S119596","volume":"8","author":"CM Dixon","year":"2016","unstructured":"Dixon CM, Cedano ER, Pacik D, Vit V, Varga G, Wagrell L, et al. Two-year results after convective radiofrequency water vapor thermal therapy of symptomatic Benign prostatic hyperplasia. Res Rep Urol. 2016;8:207\u201316. https:\/\/doi.org\/10.2147\/rru.S119596.","journal-title":"Res Rep Urol"},{"key":"1091_CR38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5152\/tud.2022.22004","volume":"48","author":"K Dogan","year":"2022","unstructured":"Dogan K, Erbagci A, Sen H, Kervancioglu S, Erturhan MS, Seckiner \u0130, et al. Clinical outcomes of prostatic artery embolization in patients with Benign prostatic hyperplasia: a prospective clinical study. Turk J Urol. 2022;48:215\u201321. https:\/\/doi.org\/10.5152\/tud.2022.22004.","journal-title":"Turk J Urol"},{"key":"1091_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1089\/end.2022.0226","volume":"37","author":"D Elterman","year":"2023","unstructured":"Elterman D, Alshak MN, Martinez Diaz S, Shore N, Gittleman M, Motola J, et al. An evaluation of sexual function in the treatment of lower urinary tract symptoms secondary to Benign prostatic hyperplasia in men treated with the temporarily implanted nitinol device. J Endourol. 2023;37:74\u201379. https:\/\/doi.org\/10.1089\/end.2022.0226.","journal-title":"J Endourol"},{"key":"1091_CR40","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/bju.15753","volume":"130","author":"D Elterman","year":"2022","unstructured":"Elterman D, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC. Rez\u016bm therapy for \u226580-mL Benign prostatic enlargement: a large, multicentre cohort study. BJU Int. 2022;130:522\u20137. https:\/\/doi.org\/10.1111\/bju.15753.","journal-title":"BJU Int"},{"key":"1091_CR41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.urology.2022.02.001","volume":"165","author":"D Elterman","year":"2022","unstructured":"Elterman D, Bhojani N, Vannabouathong C, Chughtai B, Zorn KC. Large, multi-center, prospective registry of rez\u016bm water vapor therapy for Benign prostatic hyperplasia. Urology. 2022;165:261\u20137. https:\/\/doi.org\/10.1016\/j.urology.2022.02.001.","journal-title":"Urology"},{"key":"1091_CR42","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1007\/s00345-021-03685-7","volume":"39","author":"N Frego","year":"2021","unstructured":"Frego N, Saita A, Casale P, Diana P, Contieri R, Avolio PP, et al. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of Benign prostatic hyperplasia: a single institutional experience. World J Urol. 2021;39:3867\u201373. https:\/\/doi.org\/10.1007\/s00345-021-03685-7.","journal-title":"World J Urol"},{"key":"1091_CR43","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fruro.2022.990560","volume":"ume 2","author":"J Ghahhari","year":"2022","unstructured":"Ghahhari J, Sountoulides P, Campobasso D, Faieta A, Sessa F, Viola L, et al. Mid-term results of water vapor thermal therapy in patients with lower urinary tract symptoms related to Benign prostatic hyperplasia. Brief Res Rep Front Urol. 2022;ume 2:2022 https:\/\/doi.org\/10.3389\/fruro.2022.990560.","journal-title":"Brief Res Rep Front Urol"},{"key":"1091_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuroe.2025.501708","volume":"49","author":"C Gonz\u00e1lez Enguita","year":"2025","unstructured":"Gonz\u00e1lez Enguita C, L\u00f3pez Mart\u00edn L, Herranz Fern\u00e1ndez LM, Sinues Ojas B, Barrera Rodr\u00edguez C, Extramiana Cameno J, et al. Multicenter study of the impact of Urolift\u00ae implantation in patients undergoing medical treatment for lower urinary tract symptoms secondary to Benign prostatic hyperplasia. Actas Urol Esp (Engl Ed). 2025;49:501708. https:\/\/doi.org\/10.1016\/j.acuroe.2025.501708.","journal-title":"Actas Urol Esp (Engl Ed)"},{"key":"1091_CR45","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/bju.13714","volume":"119","author":"C Gratzke","year":"2017","unstructured":"Gratzke C, Barber N, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. BJU Int. 2017;119:767\u201375. https:\/\/doi.org\/10.1111\/bju.13714.","journal-title":"BJU Int"},{"key":"1091_CR46","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/jsxmed\/qdae087","volume":"21","author":"N Hawks-Ladds","year":"2024","unstructured":"Hawks-Ladds N, Cook R, Babar M, Zhu M, Schulz A, Loloi J, et al. Four years of real-world sexual function outcomes after Rezum therapy in men with and without baseline erectile dysfunction. J Sex Med. 2024;21:777\u201386. https:\/\/doi.org\/10.1093\/jsxmed\/qdae087.","journal-title":"J Sex Med"},{"key":"1091_CR47","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/upj.0000000000000596","volume":"11","author":"N Hawks-Ladds","year":"2024","unstructured":"Hawks-Ladds N, Tawfik MM, Babar M, Zhu M, Loloi J, Labagnara K, et al. Long-term water vapor thermal therapy outcomes across a broad range of prostate volumes. Urol Pr. 2024;11:727\u201334. https:\/\/doi.org\/10.1097\/upj.0000000000000596.","journal-title":"Urol Pr"},{"key":"1091_CR48","doi-asserted-by":"publisher","unstructured":"Jankauskas T, Bur\u017einskis E, Kaupas RS, Basevi\u010dius A, Jievaltas M. Prostatic artery embolization as a treatment option for symptomatic Benign prostatic hyperplasia: results from the prospective follow-up study in Lithuania. Medicina (Kaunas). 2023;59 https:\/\/doi.org\/10.3390\/medicina59101871","DOI":"10.3390\/medicina59101871"},{"key":"1091_CR49","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41391-024-00833-z","volume":"27","author":"SA Kaplan","year":"2024","unstructured":"Kaplan SA, Moss JL, Freedman SJ. Two-year long-term follow-up of treatment with the Optilume BPH catheter system in a randomized controlled trial for Benign prostatic hyperplasia (The PINNACLE Study). Prostate Cancer Prostatic Dis. 2024;27:531\u20136. https:\/\/doi.org\/10.1038\/s41391-024-00833-z.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"1091_CR50","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/iju.15468","volume":"31","author":"Y Kato","year":"2024","unstructured":"Kato Y, Kamatani A, Shigehara K, Mizokami A. Real-world short-term outcomes of prostate urethral lift in Japan: a prospective cohort study. Int J Urol. 2024;31:852\u20138. https:\/\/doi.org\/10.1111\/iju.15468.","journal-title":"Int J Urol"},{"key":"1091_CR51","doi-asserted-by":"publisher","first-page":"338","DOI":"10.5534\/wjmh.190015","volume":"38","author":"JH Kim","year":"2020","unstructured":"Kim JH, Lee KS, Kim TH. Evaluation of clinical outcomes of prostatic urethral lift for Benign prostatic hyperplasia: an Asian population study. World J Mens Health. 2020;38:338\u201344. https:\/\/doi.org\/10.5534\/wjmh.190015.","journal-title":"World J Mens Health"},{"key":"1091_CR52","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.prnil.2025.03.001","volume":"13","author":"EC Lim","year":"2025","unstructured":"Lim EC, Gu HM, Yu SH, Lim DG, Chung HS, Jung SI, et al. Comparison of the efficacy and safety of holmium laser enucleation of the prostate and prostate artery embolization: short-term follow-up results. Prostate Int. 2025;13:155\u201360. https:\/\/doi.org\/10.1016\/j.prnil.2025.03.001.","journal-title":"Prostate Int"},{"key":"1091_CR53","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s00270-015-1235-8","volume":"39","author":"YT Lin","year":"2016","unstructured":"Lin YT, Amouyal G, Thiounn N, Pellerin O, Pereira H, Del Giudice C, et al. Intra-vesical prostatic protrusion (IPP) can be reduced by prostatic artery embolization. Cardiovasc Inter Radio. 2016;39:690\u20135. https:\/\/doi.org\/10.1007\/s00270-015-1235-8.","journal-title":"Cardiovasc Inter Radio"},{"key":"1091_CR54","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.diii.2023.12.006","volume":"105","author":"R Loffroy","year":"2024","unstructured":"Loffroy R, Quirantes A, Guillen K, Mazit A, Comby PO, Aho-Gl\u00e9l\u00e9 LS, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for symptomatic Benign prostatic hyperplasia: a six-month outcome analysis in 103 patients. Diagn Inter Imaging. 2024;105:129\u201336. https:\/\/doi.org\/10.1016\/j.diii.2023.12.006.","journal-title":"Diagn Inter Imaging"},{"key":"1091_CR55","doi-asserted-by":"publisher","unstructured":"Lombardo R, Santarelli V, Turchi B, Santoro G, Guercio A, Franco A, et al. Evaluation of peri-operative outcomes after prostatic urethral lift with emphasis on urodynamic changes, symptom improvement and sexual function. Diagnostics (Basel). 2024;14 https:\/\/doi.org\/10.3390\/diagnostics14192110","DOI":"10.3390\/diagnostics14192110"},{"key":"1091_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.fjurol.2025.102872","volume":"35","author":"T Long Depaquit","year":"2025","unstructured":"Long Depaquit T, Reus R, Uleri A, Bastide C, Berchiche W, Peyrottes A, et al. Comparative analysis of functional and economic outcomes of prostatic urethral lift and water vapor thermal therapy for male LUTS: a French perspective. Fr J Urol. 2025;35:102872. https:\/\/doi.org\/10.1016\/j.fjurol.2025.102872.","journal-title":"Fr J Urol"},{"key":"1091_CR57","doi-asserted-by":"publisher","unstructured":"Manfredi C, Spirito L, Quattrone C, Bottone F, Romano L, Balsamo R, et al. Rez\u016bm water vapor therapy vs. thulium laser enucleation for the treatment of Benign prostatic hyperplasia in patients with large prostates: a multicenter prospective comparative study. Prostate Cancer Prostatic Dis. 2025;https:\/\/doi.org\/10.1038\/s41391-025-00971-y","DOI":"10.1038\/s41391-025-00971-y"},{"key":"1091_CR58","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1007\/s00270-020-02520-7","volume":"43","author":"L Marzano","year":"2020","unstructured":"Marzano L, Thiounn N, Pereira H, Pellerin O, Dariane C, Del Giudice C, et al. Prostatic artery embolization allows to maintain full sexual activity in patients suffering from bothersome lower urinary tracts symptoms related to Benign prostatic hyperplasia. Cardiovasc Inter Radio. 2020;43:1202\u20137. https:\/\/doi.org\/10.1007\/s00270-020-02520-7.","journal-title":"Cardiovasc Inter Radio"},{"key":"1091_CR59","doi-asserted-by":"publisher","first-page":"100454","DOI":"10.1016\/j.esxm.2021.100454","volume":"9","author":"KT McVary","year":"2021","unstructured":"McVary KT, El-Arabi A, Roehrborn C. Preservation of sexual function 5 years after water vapor thermal therapy for Benign prostatic hyperplasia. Sex Med. 2021;9:100454 https:\/\/doi.org\/10.1016\/j.esxm.2021.100454.","journal-title":"Sex Med"},{"key":"1091_CR60","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jsxm.2016.03.372","volume":"13","author":"KT McVary","year":"2016","unstructured":"McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Erectile and ejaculatory function preserved with convective water vapor energy treatment of lower urinary tract symptoms secondary to Benign prostatic hyperplasia: randomized controlled study. J Sex Med. 2016;13:924\u201333. https:\/\/doi.org\/10.1016\/j.jsxm.2016.03.372.","journal-title":"J Sex Med"},{"key":"1091_CR61","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/ju.0000000000001778","volume":"206","author":"KT McVary","year":"2021","unstructured":"McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to Benign prostatic hyperplasia. J Urol. 2021;206:715\u201324. https:\/\/doi.org\/10.1097\/ju.0000000000001778.","journal-title":"J Urol"},{"key":"1091_CR62","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jsxm.2018.10.006","volume":"15","author":"KT McVary","year":"2018","unstructured":"McVary KT, Rogers T, Mahon J, Gupta NK. Is sexual function better preserved after water vapor thermal therapy or medical therapy for lower urinary tract symptoms due to Benign prostatic hyperplasia?. J Sex Med. 2018;15:1728\u201338. https:\/\/doi.org\/10.1016\/j.jsxm.2018.10.006.","journal-title":"J Sex Med"},{"key":"1091_CR63","doi-asserted-by":"publisher","first-page":"471","DOI":"10.23736\/s2724-6051.23.05270-9","volume":"75","author":"P Minafra","year":"2023","unstructured":"Minafra P, G DER, Gerbasi S, Cindolo L, Battaglia M, Ditonno P. Three years outcomes of transperineal laser ablation of the prostate. Minerva Urol Nephrol. 2023;75:471\u20138. https:\/\/doi.org\/10.23736\/s2724-6051.23.05270-9.","journal-title":"Minerva Urol Nephrol"},{"key":"1091_CR64","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1007\/s11255-025-04463-9","volume":"57","author":"A Minore","year":"2025","unstructured":"Minore A, Cacciatore L, Ferrari G, Siena G, Balsamo R, Morselli S, et al. Safety and efficacy of WVTT (Rezum) in young men: preliminary data. Int Urol Nephrol. 2025;57:2853\u20139. https:\/\/doi.org\/10.1007\/s11255-025-04463-9.","journal-title":"Int Urol Nephrol"},{"key":"1091_CR65","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.euf.2024.03.001","volume":"10","author":"G M\u00fcllhaupt","year":"2024","unstructured":"M\u00fcllhaupt G, Hechelhammer L, Graf N, Mordasini L, Schmid HP, Engeler DS, et al. Prostatic artery embolisation versus transurethral resection of the prostate for Benign prostatic obstruction: 5-year outcomes of a randomised, open-label, noninferiority trial. Eur Urol Focus. 2024;10:788\u201395. https:\/\/doi.org\/10.1016\/j.euf.2024.03.001.","journal-title":"Eur Urol Focus"},{"key":"1091_CR66","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00345-024-05002-4","volume":"42","author":"V Nguyen","year":"2024","unstructured":"Nguyen V, Winograd J, Codelia-Anjum AJ, Zorn KC, Elterman D, Bhojani N, et al. Feasibility assessment of catheter-free water vapor thermal therapy for treatment of Benign prostatic hyperplasia. World J Urol. 2024;42:383 https:\/\/doi.org\/10.1007\/s00345-024-05002-4.","journal-title":"World J Urol"},{"key":"1091_CR67","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00345-025-05644-y","volume":"43","author":"O \u00d6zkaptan","year":"2025","unstructured":"\u00d6zkaptan O, Sevin\u00e7 C, \u00c7anakc\u0131 C, Aydo\u011fan TB, T\u00fcrky\u0131lmaz O, Mert MS, et al. Comparison of outcome for holmium laser enucleation prostate and Rezum system in Benign prostate hyperplasia: a matched pair analysis. World J Urol. 2025;43:242 https:\/\/doi.org\/10.1007\/s00345-025-05644-y.","journal-title":"World J Urol"},{"key":"1091_CR68","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1177\/0846537120939930","volume":"72","author":"NR Patel","year":"2021","unstructured":"Patel NR, Elterman DS, Thulasidasan N, Altman R, Tai E, Zener R, et al. Initial canadian experience of prostate artery embolization for symptomatic Benign prostatic hyperplasia: midterm outcomes. Can Assoc Radio J. 2021;72:876\u201382. https:\/\/doi.org\/10.1177\/0846537120939930.","journal-title":"Can Assoc Radio J"},{"key":"1091_CR69","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1007\/s00330-012-2714-9","volume":"23","author":"JM Pisco","year":"2013","unstructured":"Pisco JM, Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to Benign hyperplasia: results of short- and mid-term follow-up. Eur Radio. 2013;23:2561\u201372. https:\/\/doi.org\/10.1007\/s00330-012-2714-9.","journal-title":"Eur Radio"},{"key":"1091_CR70","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.jvir.2016.04.001","volume":"27","author":"JM Pisco","year":"2016","unstructured":"Pisco JM, Bilhim T, Pinheiro LC, Fernandes L, Pereira J, Costa NV, et al. Medium- and long-term outcome of prostate artery embolization for patients with Benign prostatic hyperplasia: results in 630 patients. J Vasc Inter Radio. 2016;27:1115\u201322. https:\/\/doi.org\/10.1016\/j.jvir.2016.04.001.","journal-title":"J Vasc Inter Radio"},{"key":"1091_CR71","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1148\/radiol.12111601","volume":"266","author":"J Pisco","year":"2013","unstructured":"Pisco J, Campos Pinheiro L, Bilhim T, Duarte M, Rio Tinto H, Fernandes L, et al. Prostatic arterial embolization for Benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013;266:668\u201377. https:\/\/doi.org\/10.1148\/radiol.12111601.","journal-title":"Radiology"},{"key":"1091_CR72","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s00270-025-03966-3","volume":"48","author":"A Richardson","year":"2025","unstructured":"Richardson A, Bhatia A, Maini A, Richardson K, Issa C, Strauber Z, et al. Impact on Sexual Function of Protective Coil Embolization of Penile Collaterals During Prostatic Artery Embolization. CardioVascular Interventional Radio. 2025;48:512\u201321. https:\/\/doi.org\/10.1007\/s00270-025-03966-3.","journal-title":"CardioVascular Interventional Radio"},{"key":"1091_CR73","first-page":"8802","volume":"24","author":"CG Roehrborn","year":"2017","unstructured":"Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, et al. Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol. 2017;24:8802\u201313.","journal-title":"Can J Urol"},{"key":"1091_CR74","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.euf.2020.12.013","volume":"8","author":"CG Roehrborn","year":"2022","unstructured":"Roehrborn CG, Rukstalis DB. Prostatic urethral lift versus medical therapy: examining the impact on sexual function in men with Benign prostatic hyperplasia. Eur Urol Focus. 2022;8:217\u201327. https:\/\/doi.org\/10.1016\/j.euf.2020.12.013.","journal-title":"Eur Urol Focus"},{"key":"1091_CR75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.urology.2018.07.012","volume":"120","author":"R Salem","year":"2018","unstructured":"Salem R, Hairston J, Hohlastos E, Riaz A, Kallini J, Gabr A, et al. Prostate artery embolization for lower urinary tract symptoms secondary to Benign prostatic hyperplasia: results from a prospective FDA-approved investigational device exemption study. Urology. 2018;120:205\u201310. https:\/\/doi.org\/10.1016\/j.urology.2018.07.012.","journal-title":"Urology"},{"key":"1091_CR76","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/iju.15410","volume":"31","author":"M Samir","year":"2024","unstructured":"Samir M, Elaal AAA, Gad KAS, Basyony MW. Two-year follow-up comparing Rez\u016bm therapy versus bipolar transurethral resection of the prostate for treating Benign prostatic hyperplasia. A prospective randomized study. Int J Urol. 2024;31:545\u201350. https:\/\/doi.org\/10.1111\/iju.15410.","journal-title":"Int J Urol"},{"key":"1091_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100672","volume":"31","author":"M Sapoval","year":"2023","unstructured":"Sapoval M, Thiounn N, Descazeaud A, D\u00e9an C, Ruffion A, Pagnoux G, et al. Prostatic artery embolisation versus medical treatment in patients with Benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur. 2023;31:100672. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100672.","journal-title":"Lancet Reg Health Eur"},{"key":"1091_CR78","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.3389\/fruro.2022.969208","volume":"ume 2","author":"F Sessa","year":"2022","unstructured":"Sessa F, Polverino P, Bisegna C, Siena G, Lo Re M, Spatafora P, et al. Transperineal laser ablation of the prostate with EchoLaser\u2122 system: perioperative and short-term functional and sexual outcomes. Brief Res Rep Front Urol. 2022;ume 2:2022 https:\/\/doi.org\/10.3389\/fruro.2022.969208.","journal-title":"Brief Res Rep Front Urol"},{"key":"1091_CR79","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/03915603241277905","volume":"92","author":"M Sheba","year":"2025","unstructured":"Sheba M, El Gamal F, Abd El Wahed M, Kotb S, Meshref A, Aly Hussein H, et al. Randomised controlled trial comparing safety and efficacy of Urolift to monopolar TURP. Urologia. 2025;92:59\u201364. https:\/\/doi.org\/10.1177\/03915603241277905.","journal-title":"Urologia"},{"key":"1091_CR80","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1007\/s00345-021-03642-4","volume":"39","author":"G Siena","year":"2021","unstructured":"Siena G, Cindolo L, Ferrari G, Maruzzi D, Fasolis G, Condorelli SV, et al. Water vapor therapy (Rez\u016bm) for lower urinary tract symptoms related to Benign prostatic hyperplasia: early results from the first Italian multicentric study. World J Urol. 2021;39:3875\u201380. https:\/\/doi.org\/10.1007\/s00345-021-03642-4.","journal-title":"World J Urol"},{"key":"1091_CR81","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.eururo.2015.04.024","volume":"68","author":"J S\u00f8nksen","year":"2015","unstructured":"S\u00f8nksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2015.04.024.","journal-title":"Eur Urol"},{"key":"1091_CR82","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.euf.2022.01.011","volume":"8","author":"AT Theurich","year":"2022","unstructured":"Theurich AT, Leistritz L, Leucht K, Franiel T, Teichgr\u00e4ber U, Foller S, et al. Influence of prostate artery embolization on different qualities of lower urinary tract symptoms due to Benign prostatic obstruction. Eur Urol Focus. 2022;8:1323\u201330. https:\/\/doi.org\/10.1016\/j.euf.2022.01.011.","journal-title":"Eur Urol Focus"},{"key":"1091_CR83","doi-asserted-by":"publisher","first-page":"569.e1","DOI":"10.1016\/j.crad.2019.03.006","volume":"74","author":"N Thulasidasan","year":"2019","unstructured":"Thulasidasan N, Kok HK, Elhage O, Clovis S, Popert R, Sabharwal T. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up. Clin Radio. 2019;74:569.e1\u2013569.e8. https:\/\/doi.org\/10.1016\/j.crad.2019.03.006.","journal-title":"Clin Radio"},{"key":"1091_CR84","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/03915603241297137","volume":"92","author":"A Totaro","year":"2025","unstructured":"Totaro A, Gavi F, Fettucciari D, Bizzarri FP, Sanesi D, Cosenza L, et al. Efficacy of the Rez\u016bm system for lower urinary tract symptoms in patients with Benign prostatic hyperplasia: long term results from a single centre prospective study. Urologia. 2025;92:141\u20137. https:\/\/doi.org\/10.1177\/03915603241297137.","journal-title":"Urologia"},{"key":"1091_CR85","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/bco2.278","volume":"5","author":"R van Kollenburg","year":"2024","unstructured":"van Kollenburg R, van Riel L, Bloemen P, de Reijke T, Beerlage H, de Bruin D, et al. Transperineal laser ablation as treatment for Benign prostatic obstruction: Safety, feasibility and functional outcomes-A pilot study. BJUI Compass. 2024;5:52\u201359. https:\/\/doi.org\/10.1002\/bco2.278.","journal-title":"BJUI Compass"},{"key":"1091_CR86","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1743-6109.2011.02568.x","volume":"9","author":"HH Woo","year":"2012","unstructured":"Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to Benign prostatic hyperplasia. J Sex Med. 2012;9:568\u201375. https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02568.x.","journal-title":"J Sex Med"},{"key":"1091_CR87","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.diii.2022.01.003","volume":"103","author":"S Young","year":"2022","unstructured":"Young S, Moran P, Golzarian J. Ejaculatory dysfunction following prostate artery embolization: a retrospective study utilizing the male sexual health questionnaire-ejaculation dysfunction questionnaire. Diagn Inter Imaging. 2022;103:310\u20135. https:\/\/doi.org\/10.1016\/j.diii.2022.01.003.","journal-title":"Diagn Inter Imaging"},{"key":"1091_CR88","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.euf.2024.04.006","volume":"10","author":"F Ditonno","year":"2024","unstructured":"Ditonno F, Manfredi C, Licari LC, Bologna E, Franco A, Pandolfo SD, et al. Benign prostatic hyperplasia surgery: a snapshot of trends, costs, and surgical retreatment rates in the USA. Eur Urol Focus. 2024;10:826\u201332. https:\/\/doi.org\/10.1016\/j.euf.2024.04.006.","journal-title":"Eur Urol Focus"},{"key":"1091_CR89","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2020.12.019","volume":"79","author":"S Malde","year":"2021","unstructured":"Malde S, Umbach R, Wheeler JR, Lytvyn L, Cornu JN, Gacci M, et al. A systematic review of patients\u2019 values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms. Eur Urol. 2021;79:796\u2013809. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.019.","journal-title":"Eur Urol"},{"key":"1091_CR90","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jsxm.2020.07.006","volume":"17","author":"D Bouhadana","year":"2020","unstructured":"Bouhadana D, Nguyen DD, Zorn KC, Elterman DS, Bhojani N. Patient perspectives on Benign prostatic hyperplasia surgery: a focus on sexual health. J Sex Med. 2020;17:2108\u201312. https:\/\/doi.org\/10.1016\/j.jsxm.2020.07.006.","journal-title":"J Sex Med"},{"key":"1091_CR91","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/sxmrev\/qead002","volume":"11","author":"P Khooblall","year":"2023","unstructured":"Khooblall P, Bole R, Leelani N, Lundy S, Bajic P. A scoping review of ejaculatory dysfunction due to surgical treatments for Benign prostatic hyperplasia: limitations of available tools for assessment and reporting. Sex Med Rev. 2023;11:375\u201383. https:\/\/doi.org\/10.1093\/sxmrev\/qead002.","journal-title":"Sex Med Rev"},{"key":"1091_CR92","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","volume":"60","author":"RC Rosen","year":"2011","unstructured":"Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol. 2011;60:1010\u20136. https:\/\/doi.org\/10.1016\/j.eururo.2011.07.053.","journal-title":"Eur Urol"},{"key":"1091_CR93","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.eururo.2014.11.006","volume":"68","author":"L Cindolo","year":"2015","unstructured":"Cindolo L, Pirozzi L, Fanizza C, Romero M, Tubaro A, Autorino R, et al. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to Benign prostatic hyperplasia: population-based cohort study. Eur Urol. 2015;68:418\u201325. https:\/\/doi.org\/10.1016\/j.eururo.2014.11.006.","journal-title":"Eur Urol"},{"key":"1091_CR94","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.eururo.2014.06.017","volume":"67","author":"JN Cornu","year":"2015","unstructured":"Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from Benign prostatic obstruction: an update. Eur Urol. 2015;67:1066\u201396. https:\/\/doi.org\/10.1016\/j.eururo.2014.06.017.","journal-title":"Eur Urol"},{"key":"1091_CR95","doi-asserted-by":"publisher","unstructured":"Franco A, Ditonno F, Manfredi C, Bologna E, Licari LC, Orecchia L, et al. Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for Benign prostatic obstruction. Eur Urol. 2025;https:\/\/doi.org\/10.1016\/j.eururo.2025.09.004","DOI":"10.1016\/j.eururo.2025.09.004"},{"key":"1091_CR96","doi-asserted-by":"publisher","first-page":"353","DOI":"10.5489\/cuaj.8334","volume":"17","author":"NS Dean","year":"2023","unstructured":"Dean NS, Assmus MA, Lee MS, Guo JN, Krambeck AE. Benign prostatic hyperplasia surgical re-treatment after prostatic urethral lift A narrative review. Can Urol Assoc J. 2023;17:353\u20139. https:\/\/doi.org\/10.5489\/cuaj.8334.","journal-title":"Can Urol Assoc J"},{"key":"1091_CR97","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.21037\/tau-2025-568","volume":"14","author":"V Nguyen","year":"2025","unstructured":"Nguyen V, Tran E, Cerrato C, Finegan JL, Leach MC, Bechis SK. Do patients Rezum medications?-a real-world analysis of medical retreatment after water vapor thermal therapy. Transl Androl Urol. 2025;14:3546\u201353. https:\/\/doi.org\/10.21037\/tau-2025-568.","journal-title":"Transl Androl Urol"},{"key":"1091_CR98","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.euf.2022.06.007","volume":"8","author":"C Manfredi","year":"2022","unstructured":"Manfredi C, Garc\u00eda-G\u00f3mez B, Arcaniolo D, Garc\u00eda-Rojo E, Crocerossa F, Autorino R, et al. Impact of surgery for Benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function. Eur Urol Focus. 2022;8:1711\u201332. https:\/\/doi.org\/10.1016\/j.euf.2022.06.007.","journal-title":"Eur Urol Focus"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01091-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01091-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01091-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:18:49Z","timestamp":1772558329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-026-01091-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":98,"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1038\/s41391-026-01091-x","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}